DrugsControl Media Services

News Detail

Sputnik’s ‘efficacy at 95%’ , to be cheaper than US vaccines (25-11-2020)

MUMBAI, 25 NOV 2020: Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute and RDIF (Russian Direct Investment Fund), will b......
View Details

Source : The Times of India

Related News